FDA Updates » Recent Cancer-Related Approvals & Updates

FDA Updates » Recent Cancer-Related Approvals & Updates

Here are some of the recent approvals and FDA updates for cancer survivors from the United States Food and Drug Administration.

U.S. FDA declines to approve Y-mAbs's pediatric cancer drug

FDA Grants Accelerated Approval to Glofitamab-Gxbm for Selected

FDA Approvals in Oncology: April-June 2023 - American Association

FDA Pulls Authorization for Bebtelovimab Due to Nonsusceptible

PPVAE/news-vocab.json at master · WHUIR/PPVAE · GitHub

survey/db/json_search_results/ebsco_platform_query_results.json at

tweet-gender/tweets_by_gender.txt at master · myedibleenso/tweet

FDA's BsUFA III Features

BioCentury - FDA's 2022 approvals: oncology lulls while innovation

Trends in FDA-Approved Cancer Therapies

FDA spells out new systematic approach to giving out–and taking

FDA approves first targeted therapy for locally advanced or

Why Try? Class Ideas - a reusable non-linear personal web notebook

Why Try? Class Ideas - a reusable non-linear personal web notebook

2sable/dictionary.py at master · Adriandmen/2sable · GitHub